Comparison of Three Consecutive Monthly Administrations Between Aflibercept 8 mg and Brolucizumab 6 mg in Polypoidal Choroidal VasculopathyYoshiko Fukuda, Kenji Kashiwagi|Pharmaceuticals|2025Cited by 1